Structure

InChI Key IWEQQRMGNVVKQW-OQKDUQJOSA-N
Smile CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
InChI
InChI=1S/C26H28ClNO.C6H8O7/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-16H,17-20H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b26-25-;

Physicochemical Descriptors

Property Name Value
Molecular Formula C32H36ClNO8
Molecular Weight 598.09
AlogP 6.22
Hydrogen Bond Acceptor 2.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 9.0
Polar Surface Area 12.47
Molecular species BASE
Aromatic Rings 3.0
Heavy Atoms 29.0

Pharmacology

Action Mechanism of Action Reference
MODULATOR Estrogen receptor modulator DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Breast Neoplasms 4 D001943 ClinicalTrials
Osteoporosis 3 D010024 ClinicalTrials
Fractures, Bone 3 D050723 ClinicalTrials

Related Entries

Scaffolds

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Reproductive system and breast disorders
14.21
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
11.48
General disorders and administration site conditions
9.84
Skin and subcutaneous tissue disorders
9.84
Respiratory, thoracic and mediastinal disorders
7.65
Vascular disorders
6.56
Investigations
6.01
Hepatobiliary disorders
4.92
Immune system disorders
4.92
Injury, poisoning and procedural complications
4.92
Blood and lymphatic system disorders
3.28
Gastrointestinal disorders
3.28
Nervous system disorders
3.28
Psychiatric disorders
3.28
Infections and infestations
2.19
Metabolism and nutrition disorders
2.19

Cross References

Resources Reference
ChEBI 9636
ChEMBL CHEMBL1200675
EPA CompTox DTXSID2021367
FDA SRS 2498Y783QT
KEGG C08166
PubChem 3005572
SureChEMBL SCHEMBL4564
ZINC ZINC12404516